Sirolimus-Coated Balloons Reduce Major Adverse Limb Events at One Year: NEJM
An open-label, prospective, large-scale trial was carried out to evaluate the benefits of coating these balloons with sirolimus, which is an antiproliferative drug. The trial followed a noninferiority approach using…